{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:52:14Z","timestamp":1793040734138,"version":"4.5.0"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2020,10,10]],"date-time":"2020-10-10T00:00:00Z","timestamp":1602288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,10]],"date-time":"2020-10-10T00:00:00Z","timestamp":1602288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose of Review<\/jats:title>\n                <jats:p>Dilated cardiomyopathy (DCM) frequently involves an underlying genetic etiology, but the clinical approach for genetic diagnosis and application of results in clinical practice can be complex.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Recent Findings<\/jats:title>\n                <jats:p>International sequence databases described the landscape of genetic variability across populations, which informed guidelines for the interpretation of DCM gene variants. New evidence indicates that loss-of-function mutations in filamin C (<jats:italic>FLNC<\/jats:italic>) contribute to DCM and portend high risk of ventricular arrhythmia.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Summary<\/jats:title>\n                <jats:p>A clinical framework aids in referring patients for DCM genetic testing and applying results to patient care. Results of genetic testing can change medical management, particularly in a subset of genes that increase risk for life-threatening ventricular arrhythmias, and can influence decisions for defibrillator therapy. Clinical screening and cascade genetic testing of family members should be diligently pursued to identify those at risk of developing DCM.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s11886-020-01423-w","type":"journal-article","created":{"date-parts":[[2020,10,10]],"date-time":"2020-10-10T17:02:42Z","timestamp":1602349362000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Clinical Implications of the Genetic Architecture of Dilated Cardiomyopathy"],"prefix":"10.1007","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3676-0680","authenticated-orcid":false,"given":"Lisa D.","family":"Wilsbacher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,10]]},"reference":[{"issue":"23","key":"1423_CR1","doi-asserted-by":"publisher","first-page":"e579","DOI":"10.1161\/CIR.0000000000000455","volume":"134","author":"B Bozkurt","year":"2016","unstructured":"Bozkurt B, Colvin M, Cook J, Cooper LT, Deswal A, Fonarow GC, et al. Current diagnostic and treatment strategies for specific dilated cardiomyopathies: a scientific statement from the American Heart Association. Circulation. 2016;134(23):e579\u2013646. https:\/\/doi.org\/10.1161\/CIR.0000000000000455.","journal-title":"Circulation."},{"issue":"23","key":"1423_CR2","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1093\/eurheartj\/ehv727","volume":"37","author":"YM Pinto","year":"2016","unstructured":"Pinto YM, Elliott PM, Arbustini E, Adler Y, Anastasakis A, Bohm M, et al. Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non- dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases. Eur Heart J. 2016;37(23):1850\u20138. https:\/\/doi.org\/10.1093\/eurheartj\/ehv727.","journal-title":"Eur Heart J"},{"issue":"11","key":"1423_CR3","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.jchf.2015.06.012","volume":"3","author":"S Shore","year":"2015","unstructured":"Shore S, Grau-Sepulveda MV, Bhatt DL, Heidenreich PA, Eapen ZJ, Hernandez AF, et al. Characteristics, treatments, and outcomes of hospitalized heart failure patients stratified by etiologies of cardiomyopathy. JACC Heart Fail. 2015;3(11):906\u201316. https:\/\/doi.org\/10.1016\/j.jchf.2015.06.012.","journal-title":"JACC Heart Fail"},{"issue":"8","key":"1423_CR4","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/gim.2013.204","volume":"16","author":"TJ Pugh","year":"2014","unstructured":"Pugh TJ, Kelly MA, Gowrisankar S, Hynes E, Seidman MA, Baxter SM, et al. The landscape of genetic variation in dilated cardiomyopathy as surveyed by clinical DNA sequencing. Genet Med. 2014;16(8):601\u20138. https:\/\/doi.org\/10.1038\/gim.2013.204.","journal-title":"Genet Med"},{"issue":"2","key":"1423_CR5","doi-asserted-by":"publisher","first-page":"e002480","DOI":"10.1161\/CIRCGEN.119.002480","volume":"13","author":"A Morales","year":"2020","unstructured":"Morales A, Kinnamon DD, Jordan E, Platt J, Vatta M, Dorschner MO, et al. Variant interpretation for dilated cardiomyopathy: refinement of the American College of Medical Genetics and Genomics\/ClinGen guidelines for the DCM precision medicine study. Circ Genom Precis Med. 2020;13(2):e002480. https:\/\/doi.org\/10.1161\/CIRCGEN.119.002480.","journal-title":"Circ Genom Precis Med"},{"key":"1423_CR6","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1146\/annurev-pathol-020712-164026","volume":"8","author":"SD Boyd","year":"2013","unstructured":"Boyd SD. Diagnostic applications of high-throughput DNA sequencing. Annu Rev Pathol. 2013;8:381\u2013410. https:\/\/doi.org\/10.1146\/annurev-pathol-020712-164026.","journal-title":"Annu Rev Pathol"},{"issue":"2","key":"1423_CR7","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/gim.2016.90","volume":"19","author":"R Walsh","year":"2017","unstructured":"Walsh R, Thomson KL, Ware JS, Funke BH, Woodley J, McGuire KJ, et al. Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples. Genet Med. 2017;19(2):192\u2013203. https:\/\/doi.org\/10.1038\/gim.2016.90.","journal-title":"Genet Med"},{"issue":"9","key":"1423_CR8","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/nrcardio.2013.105","volume":"10","author":"RE Hershberger","year":"2013","unstructured":"Hershberger RE, Hedges DJ, Morales A. Dilated cardiomyopathy: the complexity of a diverse genetic architecture. Nat Rev Cardiol. 2013;10(9):531\u201347. https:\/\/doi.org\/10.1038\/nrcardio.2013.105.","journal-title":"Nat Rev Cardiol"},{"issue":"3","key":"1423_CR9","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1161\/01.cir.80.3.564","volume":"80","author":"MB Codd","year":"1989","unstructured":"Codd MB, Sugrue DD, Gersh BJ, Melton LJ 3rd. Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted County, Minnesota, 1975-1984. Circulation. 1989;80(3):564\u201372. https:\/\/doi.org\/10.1161\/01.cir.80.3.564.","journal-title":"Circulation."},{"issue":"6","key":"1423_CR10","doi-asserted-by":"publisher","first-page":"e137","DOI":"10.1161\/CIR.0000000000000509","volume":"136","author":"CW Yancy","year":"2017","unstructured":"Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Colvin MM, et al. 2017 ACC\/AHA\/HFSA focused update of the 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines and the Heart Failure Society of America. Circulation. 2017;136(6):e137\u2013e61. https:\/\/doi.org\/10.1161\/CIR.0000000000000509.","journal-title":"Circulation."},{"issue":"21","key":"1423_CR11","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","volume":"381","author":"JJV McMurray","year":"2019","unstructured":"McMurray JJV, Solomon SD, Inzucchi SE, Kober L, Kosiborod MN, Martinez FA, et al. Dapagliflozin in patients with heart failure and reduced ejection fraction. N Engl J Med. 2019;381(21):1995\u20132008. https:\/\/doi.org\/10.1056\/NEJMoa1911303.","journal-title":"N Engl J Med"},{"issue":"3","key":"1423_CR12","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.1016\/j.jacc.2012.11.007","volume":"61","author":"AE Epstein","year":"2013","unstructured":"Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA 3rd, Freedman RA, Gettes LS, et al. 2012 ACCF\/AHA\/HRS focused update incorporated into the ACCF\/AHA\/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation\/American Heart Association task force on practice guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2013;61(3):e6\u201375. https:\/\/doi.org\/10.1016\/j.jacc.2012.11.007.","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"1423_CR13","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1002\/ejhf.1216","volume":"20","author":"BP Halliday","year":"2018","unstructured":"Halliday BP, Gulati A, Ali A, Newsome S, Lota A, Tayal U, et al. Sex- and age- based differences in the natural history and outcome of dilated cardiomyopathy. Eur J Heart Fail. 2018;20(10):1392\u2013400. https:\/\/doi.org\/10.1002\/ejhf.1216.","journal-title":"Eur J Heart Fail"},{"key":"1423_CR14","doi-asserted-by":"publisher","unstructured":"Sidhu K, Han L, Picard KCI, Tedrow UB, Lakdawala NK. Ventricular tachycardia in cardiolaminopathy: characteristics and considerations for device programming. Heart Rhythm. 2020. https:\/\/doi.org\/10.1016\/j.hrthm.2020.05.023.","DOI":"10.1016\/j.hrthm.2020.05.023"},{"issue":"41","key":"1423_CR15","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1093\/eurheartj\/ehv316","volume":"36","author":"SG Priori","year":"2015","unstructured":"Priori SG, Blomstrom-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J, et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the task force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J. 2015;36(41):2793\u2013867. https:\/\/doi.org\/10.1093\/eurheartj\/ehv316.","journal-title":"Eur Heart J"},{"key":"1423_CR16","unstructured":"Wetterstrand KA. DNA sequencing costs: data from the NHGRI genome sequencing program (GSP) www.genome.gov\/sequencingcostsdata. Accessed August 5, 2020."},{"issue":"9","key":"1423_CR17","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/s41436-018-0039-z","volume":"20","author":"RE Hershberger","year":"2018","unstructured":"\u2022 Hershberger RE, Givertz MM, Ho CY, Judge DP, Kantor PF, McBride KL, et al. Genetic evaluation of cardiomyopathy: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2018;20(9):899\u2013909. https:\/\/doi.org\/10.1038\/s41436-018-0039-z. This document provides expert consensus recommendations for genetic testing in individuals with cardiomyopathy.","journal-title":"Genet Med"},{"issue":"5","key":"1423_CR18","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.cardfail.2018.03.004","volume":"24","author":"RE Hershberger","year":"2018","unstructured":"Hershberger RE, Givertz MM, Ho CY, Judge DP, Kantor PF, McBride KL, et al. Genetic evaluation of cardiomyopathy-a Heart Failure Society of America practice guideline. J Card Fail. 2018;24(5):281\u2013302. https:\/\/doi.org\/10.1016\/j.cardfail.2018.03.004.","journal-title":"J Card Fail"},{"issue":"3","key":"1423_CR19","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1161\/CIRCGENETICS.109.903898","volume":"3","author":"YM Hoedemaekers","year":"2010","unstructured":"Hoedemaekers YM, Caliskan K, Michels M, Frohn-Mulder I, van der Smagt JJ, Phefferkorn JE, et al. The importance of genetic counseling, DNA diagnostics, and cardiologic family screening in left ventricular noncompaction cardiomyopathy. Circ Cardiovasc Genet. 2010;3(3):232\u20139. https:\/\/doi.org\/10.1161\/CIRCGENETICS.109.903898.","journal-title":"Circ Cardiovasc Genet"},{"issue":"3","key":"1423_CR20","doi-asserted-by":"publisher","first-page":"e004682","DOI":"10.1161\/CIRCHEARTFAILURE.117.004682","volume":"11","author":"MR Hazebroek","year":"2018","unstructured":"Hazebroek MR, Krapels I, Verdonschot J, van den Wijngaard A, Vanhoutte E, Hoos M, et al. Prevalence of pathogenic gene mutations and prognosis do not differ in isolated left ventricular dysfunction compared with dilated cardiomyopathy. Circ Heart Fail. 2018;11(3):e004682. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.117.004682.","journal-title":"Circ Heart Fail"},{"issue":"20","key":"1423_CR21","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1161\/CIRCULATIONAHA.109.929646","volume":"121","author":"KY van Spaendonck-Zwarts","year":"2010","unstructured":"van Spaendonck-Zwarts KY, van Tintelen JP, van Veldhuisen DJ, van der Werf R, Jongbloed JD, Paulus WJ, et al. Peripartum cardiomyopathy as a part of familial dilated cardiomyopathy. Circulation. 2010;121(20):2169\u201375. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.929646.","journal-title":"Circulation."},{"issue":"20","key":"1423_CR22","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1161\/CIRCULATIONAHA.109.931220","volume":"121","author":"A Morales","year":"2010","unstructured":"Morales A, Painter T, Li R, Siegfried JD, Li D, Norton N, et al. Rare variant mutations in pregnancy-associated or peripartum cardiomyopathy. Circulation. 2010;121(20):2176\u201382. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.931220.","journal-title":"Circulation."},{"issue":"6","key":"1423_CR23","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1093\/eurjhf\/hfr040","volume":"13","author":"SP Krul","year":"2011","unstructured":"Krul SP, van der Smagt JJ, van den Berg MP, Sollie KM, Pieper PG, van Spaendonck-Zwarts KY. Systematic review of pregnancy in women with inherited cardiomyopathies. Eur J Heart Fail. 2011;13(6):584\u201394. https:\/\/doi.org\/10.1093\/eurjhf\/hfr040.","journal-title":"Eur J Heart Fail"},{"issue":"7809","key":"1423_CR24","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","volume":"581","author":"KJ Karczewski","year":"2020","unstructured":"\u2022\u2022 Karczewski KJ, Francioli LC, Tiao G, Cummings BB, Alfoldi J, Wang Q, et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2020;581(7809):434\u201343. https:\/\/doi.org\/10.1038\/s41586-020-2308-7. This paper presents the Genome Aggregation Database (gnomAD), which describes the landscape of genetic variation across diverse populations and is critically important for gene variant interpretation.","journal-title":"Nature"},{"issue":"D1","key":"1423_CR25","doi-asserted-by":"publisher","first-page":"D1062","DOI":"10.1093\/nar\/gkx1153","volume":"46","author":"MJ Landrum","year":"2018","unstructured":"Landrum MJ, Lee JM, Benson M, Brown GR, Chao C, Chitipiralla S, et al. ClinVar: improving access to variant interpretations and supporting evidence. Nucleic Acids Res. 2018;46(D1):D1062\u2013D7. https:\/\/doi.org\/10.1093\/nar\/gkx1153.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"1423_CR26","doi-asserted-by":"publisher","first-page":"D877","DOI":"10.1093\/nar\/gkw1012","volume":"45","author":"N Rappaport","year":"2017","unstructured":"Rappaport N, Twik M, Plaschkes I, Nudel R, Iny Stein T, Levitt J, et al. MalaCards: an amalgamated human disease compendium with diverse clinical and genetic annotation and structured search. Nucleic Acids Res. 2017;45(D1):D877\u2013D87. https:\/\/doi.org\/10.1093\/nar\/gkw1012.","journal-title":"Nucleic Acids Res"},{"issue":"23","key":"1423_CR27","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1056\/NEJMsr1406261","volume":"372","author":"HL Rehm","year":"2015","unstructured":"Rehm HL, Berg JS, Brooks LD, Bustamante CD, Evans JP, Landrum MJ, et al. ClinGen--the clinical genome resource. N Engl J Med. 2015;372(23):2235\u201342. https:\/\/doi.org\/10.1056\/NEJMsr1406261.","journal-title":"N Engl J Med"},{"issue":"3","key":"1423_CR28","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/gim.2017.218","volume":"20","author":"MA Kelly","year":"2018","unstructured":"Kelly MA, Caleshu C, Morales A, Buchan J, Wolf Z, Harrison SM, et al. Adaptation and validation of the ACMG\/AMP variant classification framework for MYH7-associated inherited cardiomyopathies: recommendations by ClinGen's inherited cardiomyopathy expert panel. Genet Med. 2018;20(3):351\u20139. https:\/\/doi.org\/10.1038\/gim.2017.218.","journal-title":"Genet Med"},{"issue":"5","key":"1423_CR29","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"\u2022\u2022 Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405\u201324. https:\/\/doi.org\/10.1038\/gim.2015.30. This paper describes the types and relative strengths of evidence used to interpret gene variants.","journal-title":"Genet Med"},{"issue":"5","key":"1423_CR30","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.healun.2015.12.014","volume":"35","author":"S Cuenca","year":"2016","unstructured":"Cuenca S, Ruiz-Cano MJ, Gimeno-Blanes JR, Jurado A, Salas C, Gomez-Diaz I, et al. Genetic basis of familial dilated cardiomyopathy patients undergoing heart transplantation. J Heart Lung Transplant. 2016;35(5):625\u201335. https:\/\/doi.org\/10.1016\/j.healun.2015.12.014.","journal-title":"J Heart Lung Transplant"},{"issue":"6","key":"1423_CR31","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1007\/s10897-014-9743-2","volume":"23","author":"AE Prince","year":"2014","unstructured":"Prince AE, Roche MI. Genetic information, non-discrimination, and privacy protections in genetic counseling practice. J Genet Couns. 2014;23(6):891\u2013902. https:\/\/doi.org\/10.1007\/s10897-014-9743-2.","journal-title":"J Genet Couns"},{"issue":"2","key":"1423_CR32","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/ejhg.2016.155","volume":"25","author":"K Nieuwhof","year":"2017","unstructured":"Nieuwhof K, Birnie E, van den Berg MP, de Boer RA, van Haelst PL, van Tintelen JP, et al. Follow-up care by a genetic counsellor for relatives at risk for cardiomyopathies is cost-saving and well-appreciated: a randomised comparison. Eur J Hum Genet. 2017;25(2):169\u201375. https:\/\/doi.org\/10.1038\/ejhg.2016.155.","journal-title":"Eur J Hum Genet"},{"issue":"1","key":"1423_CR33","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1093\/eurheartj\/ehy730","volume":"40","author":"A Pelliccia","year":"2019","unstructured":"Pelliccia A, Solberg EE, Papadakis M, Adami PE, Biffi A, Caselli S, et al. Recommendations for participation in competitive and leisure time sport in athletes with cardiomyopathies, myocarditis, and pericarditis: position statement of the sport cardiology section of the European Association of Preventive Cardiology (EAPC). Eur Heart J. 2019;40(1):19\u201333. https:\/\/doi.org\/10.1093\/eurheartj\/ehy730.","journal-title":"Eur Heart J"},{"issue":"22","key":"1423_CR34","doi-asserted-by":"publisher","first-page":"e273","DOI":"10.1161\/CIR.0000000000000239","volume":"132","author":"BJ Maron","year":"2015","unstructured":"Maron BJ, Udelson JE, Bonow RO, Nishimura RA, Ackerman MJ, Estes NA 3rd, et al. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 3: hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy and other cardiomyopathies, and myocarditis: a scientific statement from the American Heart Association and American College of Cardiology. Circulation. 2015;132(22):e273\u201380. https:\/\/doi.org\/10.1161\/CIR.0000000000000239.","journal-title":"Circulation."},{"issue":"7616","key":"1423_CR35","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/nature19057","volume":"536","author":"M Lek","year":"2016","unstructured":"Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, Fennell T, et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature. 2016;536(7616):285\u201391. https:\/\/doi.org\/10.1038\/nature19057.","journal-title":"Nature."},{"issue":"22","key":"1423_CR36","doi-asserted-by":"publisher","first-page":"2732","DOI":"10.1093\/eurheartj\/ehm429","volume":"28","author":"YM Hoedemaekers","year":"2007","unstructured":"Hoedemaekers YM, Caliskan K, Majoor-Krakauer D, van de Laar I, Michels M, Witsenburg M, et al. Cardiac beta-myosin heavy chain defects in two families with non-compaction cardiomyopathy: linking non-compaction to hypertrophic, restrictive, and dilated cardiomyopathies. Eur Heart J. 2007;28(22):2732\u20137. https:\/\/doi.org\/10.1093\/eurheartj\/ehm429.","journal-title":"Eur Heart J"},{"issue":"23","key":"1423_CR37","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1161\/CIRCULATIONAHA.119.044934","volume":"141","author":"ED Smith","year":"2020","unstructured":"\u2022 Smith ED, Lakdawala NK, Papoutsidakis N, Aubert G, Mazzanti A, McCanta AC, et al. Desmoplakin cardiomyopathy, a fibrotic and inflammatory form of cardiomyopathy distinct from typical dilated or arrhythmogenic right ventricular cardiomyopathy. Circulation. 2020;141(23):1872\u201384. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.119.044934. Using a cohort of 107 individuals, the authors describe clinical features of DSP-mediated left ventricular-dominant arrhythmogenic cardiomyopathy.","journal-title":"Circulation"},{"issue":"18","key":"1423_CR38","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1093\/eurheartj\/ehu301","volume":"36","author":"J Haas","year":"2015","unstructured":"Haas J, Frese KS, Peil B, Kloos W, Keller A, Nietsch R, et al. Atlas of the clinical genetics of human dilated cardiomyopathy. Eur Heart J. 2015;36(18):1123\u201335a. https:\/\/doi.org\/10.1093\/eurheartj\/ehu301.","journal-title":"Eur Heart J"},{"issue":"2","key":"1423_CR39","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s00392-016-1033-6","volume":"106","author":"E Kayvanpour","year":"2017","unstructured":"Kayvanpour E, Sedaghat-Hamedani F, Amr A, Lai A, Haas J, Holzer DB, et al. Genotype-phenotype associations in dilated cardiomyopathy: meta-analysis on more than 8000 individuals. Clin Res Cardiol. 2017;106(2):127\u201339. https:\/\/doi.org\/10.1007\/s00392-016-1033-6.","journal-title":"Clin Res Cardiol"},{"issue":"1","key":"1423_CR40","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41436-018-0036-2","volume":"21","author":"C Horvat","year":"2019","unstructured":"Horvat C, Johnson R, Lam L, Munro J, Mazzarotto F, Roberts AM, et al. A gene- centric strategy for identifying disease-causing rare variants in dilated cardiomyopathy. Genet Med. 2019;21(1):133\u201343. https:\/\/doi.org\/10.1038\/s41436-018-0036-2.","journal-title":"Genet Med"},{"issue":"5","key":"1423_CR41","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1161\/CIRCULATIONAHA.119.037661","volume":"141","author":"F Mazzarotto","year":"2020","unstructured":"Mazzarotto F, Tayal U, Buchan RJ, Midwinter W, Wilk A, Whiffin N, et al. Reevaluating the genetic contribution of monogenic dilated cardiomyopathy. Circulation. 2020;141(5):387\u201398. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.119.037661.","journal-title":"Circulation."},{"key":"1423_CR42","doi-asserted-by":"publisher","unstructured":"\u2022 Musunuru K, Hershberger RE, Day SM, Klinedinst NJ, Landstrom AP, Parikh VN, et al. Genetic testing for inherited cardiovascular diseases: a scientific statement from the American Heart Association. Circ Genom Precis Med. 2020:HCG0000000000000067. https:\/\/doi.org\/10.1161\/HCG.0000000000000067. This document provides expert consensus recommendations for genetic testing in individuals with inherited cardiovascular disease, including cardiomyopathy, arrhythmia, vascular disorders, and familial hypercholesterolemia.","DOI":"10.1161\/HCG.0000000000000067"},{"issue":"3","key":"1423_CR43","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/s41436-018-0083-8","volume":"21","author":"IM Miller","year":"2019","unstructured":"Miller IM, Lewis KL, Lawal TA, Ng D, Johnston JJ, Biesecker BB, et al. Health behaviors among unaffected participants following receipt of variants of uncertain significance in cardiomyopathy-associated genes. Genet Med. 2019;21(3):748\u201352. https:\/\/doi.org\/10.1038\/s41436-018-0083-8.","journal-title":"Genet Med"},{"key":"1423_CR44","doi-asserted-by":"publisher","unstructured":"Scherr CL, Aufox S, Ross AA, Ramesh S, Wicklund CA, Smith M. What people want to know about their genes: a critical review of the literature on large- scale genome sequencing studies. Healthcare (Basel). 2018;6(3). https:\/\/doi.org\/10.3390\/healthcare6030096.","DOI":"10.3390\/healthcare6030096"},{"issue":"6","key":"1423_CR45","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1038\/s41436-018-0335-7","volume":"21","author":"GJ Tsai","year":"2019","unstructured":"Tsai GJ, Ranola JMO, Smith C, Garrett LT, Bergquist T, Casadei S, et al. Outcomes of 92 patient-driven family studies for reclassification of variants of uncertain significance. Genet Med. 2019;21(6):1435\u201342. https:\/\/doi.org\/10.1038\/s41436-018-0335-7.","journal-title":"Genet Med"},{"issue":"7","key":"1423_CR46","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1056\/NEJMoa1110186","volume":"366","author":"DS Herman","year":"2012","unstructured":"\u2022\u2022 Herman DS, Lam L, Taylor MR, Wang L, Teekakirikul P, Christodoulou D, et al. Truncations of titin causing dilated cardiomyopathy. N Engl J Med. 2012;366(7):619\u201328. https:\/\/doi.org\/10.1056\/NEJMoa1110186. This paper was the first to report the full gene sequence Titin (TTN), and it revealed the high prevalence of TTN truncating variants in DCM.","journal-title":"N Engl J Med"},{"issue":"1","key":"1423_CR47","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1161\/CIRCULATIONAHA.119.039573","volume":"140","author":"CM Haggerty","year":"2019","unstructured":"Haggerty CM, Damrauer SM, Levin MG, Birtwell D, Carey DJ, Golden AM, et al. Genomics-first evaluation of heart disease associated with titin-truncating variants. Circulation. 2019;140(1):42\u201354. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.119.039573.","journal-title":"Circulation."},{"issue":"4","key":"1423_CR48","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1161\/CIRCGENETICS.112.962928","volume":"5","author":"JR Golbus","year":"2012","unstructured":"Golbus JR, Puckelwartz MJ, Fahrenbach JP, Dellefave-Castillo LM, Wolfgeher D, McNally EM. Population-based variation in cardiomyopathy genes. Circ Cardiovasc Genet. 2012;5(4):391\u20139. https:\/\/doi.org\/10.1161\/CIRCGENETICS.112.962928.","journal-title":"Circ Cardiovasc Genet"},{"issue":"11","key":"1423_CR49","doi-asserted-by":"publisher","first-page":"e005220","DOI":"10.1161\/CIRCHEARTFAILURE.118.005220","volume":"11","author":"JAJ Verdonschot","year":"2018","unstructured":"Verdonschot JAJ, Hazebroek MR, Wang P, Sanders-van Wijk S, Merken JJ, Adriaansen YA, et al. Clinical phenotype and genotype associations with improvement in left ventricular function in dilated cardiomyopathy. Circ Heart Fail. 2018;11(11):e005220. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.118.005220.","journal-title":"Circ Heart Fail"},{"issue":"1","key":"1423_CR50","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1038\/s41598-018-20114-9","volume":"8","author":"T Tobita","year":"2018","unstructured":"Tobita T, Nomura S, Fujita T, Morita H, Asano Y, Onoue K, et al. Genetic basis of cardiomyopathy and the genotypes involved in prognosis and left ventricular reverse remodeling. Sci Rep. 2018;8(1):1998. https:\/\/doi.org\/10.1038\/s41598-018-20114-9.","journal-title":"Sci Rep"},{"issue":"4","key":"1423_CR51","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/ejhf.673","volume":"19","author":"JA Jansweijer","year":"2017","unstructured":"Jansweijer JA, Nieuwhof K, Russo F, Hoorntje ET, Jongbloed JD, Lekanne Deprez RH, et al. Truncating titin mutations are associated with a mild and treatable form of dilated cardiomyopathy. Eur J Heart Fail. 2017;19(4):512\u201321. https:\/\/doi.org\/10.1002\/ejhf.673.","journal-title":"Eur J Heart Fail"},{"issue":"6","key":"1423_CR52","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1001\/jamacardio.2017.0763","volume":"2","author":"K Luk","year":"2017","unstructured":"Luk K, Bakhsh A, Giannetti N, Elstein E, Lathrop M, Thanassoulis G, et al. Recovery in patients with dilated cardiomyopathy with loss-of-function mutations in the titin gene. JAMA Cardiol. 2017;2(6):700\u20132. https:\/\/doi.org\/10.1001\/jamacardio.2017.0763.","journal-title":"JAMA Cardiol"},{"issue":"10","key":"1423_CR53","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.jacc.2009.05.038","volume":"54","author":"KM Brauch","year":"2009","unstructured":"Brauch KM, Karst ML, Herron KJ, de Andrade M, Pellikka PA, Rodeheffer RJ, et al. Mutations in ribonucleic acid binding protein gene cause familial dilated cardiomyopathy. J Am Coll Cardiol. 2009;54(10):930\u201341. https:\/\/doi.org\/10.1016\/j.jacc.2009.05.038.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"1423_CR54","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/nm.2693","volume":"18","author":"W Guo","year":"2012","unstructured":"Guo W, Schafer S, Greaser ML, Radke MH, Liss M, Govindarajan T, et al. RBM20, a gene for hereditary cardiomyopathy, regulates titin splicing. Nat Med. 2012;18(5):766\u201373. https:\/\/doi.org\/10.1038\/nm.2693.","journal-title":"Nat Med"},{"issue":"3","key":"1423_CR55","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.hrthm.2011.10.016","volume":"9","author":"MM Refaat","year":"2012","unstructured":"Refaat MM, Lubitz SA, Makino S, Islam Z, Frangiskakis JM, Mehdi H, et al. Genetic variation in the alternative splicing regulator RBM20 is associated with dilated cardiomyopathy. Heart Rhythm. 2012;9(3):390\u20136. https:\/\/doi.org\/10.1016\/j.hrthm.2011.10.016.","journal-title":"Heart Rhythm"},{"issue":"8","key":"1423_CR56","doi-asserted-by":"publisher","first-page":"3419","DOI":"10.1172\/JCI74523","volume":"124","author":"H Maatz","year":"2014","unstructured":"Maatz H, Jens M, Liss M, Schafer S, Heinig M, Kirchner M, et al. RNA-binding protein RBM20 represses splicing to orchestrate cardiac pre-mRNA processing. J Clin Invest. 2014;124(8):3419\u201330. https:\/\/doi.org\/10.1172\/JCI74523.","journal-title":"J Clin Invest"},{"issue":"3","key":"1423_CR57","doi-asserted-by":"publisher","first-page":"e005371","DOI":"10.1161\/CIRCHEARTFAILURE.118.005371","volume":"12","author":"VN Parikh","year":"2019","unstructured":"\u2022 Parikh VN, Caleshu C, Reuter C, Lazzeroni LC, Ingles J, Garcia J, et al. Regional variation in RBM20 causes a highly penetrant arrhythmogenic cardiomyopathy. Circ Heart Fail. 2019;12(3):e005371. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.118.005371. The authors created a database of patients with RBM20 cardiomyopathy to define two regions in the gene that are enriched for cardiomyopathy-associated variants, and they used a cohort of 74 individuals to describe the high arrhythmia risk associated with RBM20 mutations.","journal-title":"Circ Heart Fail"},{"issue":"3","key":"1423_CR58","doi-asserted-by":"publisher","first-page":"e005700","DOI":"10.1161\/CIRCHEARTFAILURE.118.005700","volume":"12","author":"TM Hey","year":"2019","unstructured":"Hey TM, Rasmussen TB, Madsen T, Aagaard MM, Harbo M, Molgaard H, et al. Pathogenic RBM20-variants are associated with a severe disease expression in male patients with dilated cardiomyopathy. Circ Heart Fail. 2019;12(3):e005700. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.118.005700.","journal-title":"Circ Heart Fail"},{"issue":"5","key":"1423_CR59","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1086\/344208","volume":"71","author":"A Rampazzo","year":"2002","unstructured":"Rampazzo A, Nava A, Malacrida S, Beffagna G, Bauce B, Rossi V, et al. Mutation in human desmoplakin domain binding to plakoglobin causes a dominant form of arrhythmogenic right ventricular cardiomyopathy. Am J Hum Genet. 2002;71(5):1200\u20136. https:\/\/doi.org\/10.1086\/344208.","journal-title":"Am J Hum Genet"},{"issue":"5","key":"1423_CR60","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1161\/CIRCULATIONAHA.104.532234","volume":"112","author":"M Norman","year":"2005","unstructured":"Norman M, Simpson M, Mogensen J, Shaw A, Hughes S, Syrris P, et al. Novel mutation in desmoplakin causes arrhythmogenic left ventricular cardiomyopathy. Circulation. 2005;112(5):636\u201342. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.104.532234.","journal-title":"Circulation."},{"issue":"13","key":"1423_CR61","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1161\/CIRCULATIONAHA.106.660241","volume":"115","author":"S Sen-Chowdhry","year":"2007","unstructured":"Sen-Chowdhry S, Syrris P, Ward D, Asimaki A, Sevdalis E, McKenna WJ. Clinical and genetic characterization of families with arrhythmogenic right ventricular dysplasia\/cardiomyopathy provides novel insights into patterns of disease expression. Circulation. 2007;115(13):1710\u201320. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.660241.","journal-title":"Circulation."},{"issue":"14","key":"1423_CR62","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1093\/eurheartj\/ehu509","volume":"36","author":"A Bhonsale","year":"2015","unstructured":"Bhonsale A, Groeneweg JA, James CA, Dooijes D, Tichnell C, Jongbloed JD, et al. Impact of genotype on clinical course in arrhythmogenic right ventricular dysplasia\/cardiomyopathy-associated mutation carriers. Eur Heart J. 2015;36(14):847\u201355. https:\/\/doi.org\/10.1093\/eurheartj\/ehu509.","journal-title":"Eur Heart J"},{"issue":"12","key":"1423_CR63","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1093\/europace\/euu128","volume":"16","author":"JM Lopez-Ayala","year":"2014","unstructured":"Lopez-Ayala JM, Gomez-Milanes I, Sanchez Munoz JJ, Ruiz-Espejo F, Ortiz M, Gonzalez-Carrillo J, et al. Desmoplakin truncations and arrhythmogenic left ventricular cardiomyopathy: characterizing a phenotype. Europace. 2014;16(12):1838\u201346. https:\/\/doi.org\/10.1093\/europace\/euu128.","journal-title":"Europace."},{"issue":"12","key":"1423_CR64","doi-asserted-by":"publisher","first-page":"e002373","DOI":"10.1161\/CIRCGEN.118.002373","volume":"11","author":"K Reichl","year":"2018","unstructured":"Reichl K, Kreykes SE, Martin CM, Shenoy C. Desmoplakin variant-associated arrhythmogenic cardiomyopathy presenting as acute myocarditis. Circ Genom Precis Med. 2018;11(12):e002373. https:\/\/doi.org\/10.1161\/CIRCGEN.118.002373.","journal-title":"Circ Genom Precis Med"},{"issue":"7","key":"1423_CR65","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1002\/ajmg.a.38719","volume":"176","author":"SM Singh","year":"2018","unstructured":"Singh SM, Casey SA, Berg AA, Abdelhadi RH, Katsiyiannis WT, Bennett MK, et al. Autosomal-dominant biventricular arrhythmogenic cardiomyopathy in a large family with a novel in-frame DSP nonsense mutation. Am J Med Genet A. 2018;176(7):1622\u20136. https:\/\/doi.org\/10.1002\/ajmg.a.38719.","journal-title":"Am J Med Genet A"},{"issue":"3","key":"1423_CR66","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1093\/ehjci\/jez188","volume":"21","author":"JB Augusto","year":"2020","unstructured":"Augusto JB, Eiros R, Nakou E, Moura-Ferreira S, Treibel TA, Captur G, et al. Dilated cardiomyopathy and arrhythmogenic left ventricular cardiomyopathy: a comprehensive genotype-imaging phenotype study. Eur Heart J Cardiovasc Imaging. 2020;21(3):326\u201336. https:\/\/doi.org\/10.1093\/ehjci\/jez188.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"22","key":"1423_CR67","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1016\/j.jacc.2016.09.927","volume":"68","author":"MF Ortiz-Genga","year":"2016","unstructured":"\u2022\u2022 Ortiz-Genga MF, Cuenca S, Dal Ferro M, Zorio E, Salgado-Aranda R, Climent V, et al. Truncating FLNC mutations are associated with high-risk dilated and arrhythmogenic cardiomyopathies. J Am Coll Cardiol. 2016;68(22):2440\u201351. https:\/\/doi.org\/10.1016\/j.jacc.2016.09.927. Using a cohort of 28 families, the authors were the first to definitively link FLNC truncating variants with high-risk arrhythmogenic DCM.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"1423_CR68","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jacbts.2016.05.004","volume":"1","author":"RL Begay","year":"2016","unstructured":"Begay RL, Tharp CA, Martin A, Graw SL, Sinagra G, Miani D, et al. FLNC gene splice mutations cause dilated cardiomyopathy. JACC Basic Transl Sci. 2016;1(5):344\u201359. https:\/\/doi.org\/10.1016\/j.jacbts.2016.05.004.","journal-title":"JACC Basic Transl Sci"},{"key":"1423_CR69","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.gene.2018.03.044","volume":"659","author":"A Nozari","year":"2018","unstructured":"Nozari A, Aghaei-Moghadam E, Zeinaloo A, Mollazadeh R, Majnoon MT, Alavi A, et al. A novel splicing variant in FLNC gene responsible for a highly penetrant familial dilated cardiomyopathy in an extended Iranian family. Gene. 2018;659:160\u20137. https:\/\/doi.org\/10.1016\/j.gene.2018.03.044.","journal-title":"Gene."},{"issue":"12","key":"1423_CR70","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1186\/s13059-014-0534-8","volume":"15","author":"RC Deo","year":"2014","unstructured":"Deo RC, Musso G, Tasan M, Tang P, Poon A, Yuan C, et al. Prioritizing causal disease genes using unbiased genomic features. Genome Biol. 2014;15(12):534. https:\/\/doi.org\/10.1186\/s13059-014-0534-8.","journal-title":"Genome Biol"},{"issue":"6","key":"1423_CR71","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1161\/CIRCGENETICS.113.000578","volume":"7","author":"JR Golbus","year":"2014","unstructured":"Golbus JR, Puckelwartz MJ, Dellefave-Castillo L, Fahrenbach JP, Nelakuditi V, Pesce LL, et al. Targeted analysis of whole genome sequence data to diagnose genetic cardiomyopathy. Circ Cardiovasc Genet. 2014;7(6):751\u20139. https:\/\/doi.org\/10.1161\/CIRCGENETICS.113.000578.","journal-title":"Circ Cardiovasc Genet"},{"issue":"4","key":"1423_CR72","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.jacep.2017.12.003","volume":"4","author":"RL Begay","year":"2018","unstructured":"Begay RL, Graw SL, Sinagra G, Asimaki A, Rowland TJ, Slavov DB, et al. Filamin C truncation mutations are associated with arrhythmogenic dilated cardiomyopathy and changes in the cell-cell adhesion structures. JACC Clin Electrophysiol. 2018;4(4):504\u201314. https:\/\/doi.org\/10.1016\/j.jacep.2017.12.003.","journal-title":"JACC Clin Electrophysiol"},{"issue":"4","key":"1423_CR73","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/cge.13594","volume":"96","author":"F Ader","year":"2019","unstructured":"Ader F, De Groote P, Reant P, Rooryck-Thambo C, Dupin-Deguine D, Rambaud C, et al. FLNC pathogenic variants in patients with cardiomyopathies: prevalence and genotype-phenotype correlations. Clin Genet. 2019;96(4):317\u201329. https:\/\/doi.org\/10.1111\/cge.13594.","journal-title":"Clin Genet"},{"issue":"6","key":"1423_CR74","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1002\/humu.24004","volume":"41","author":"JAJ Verdonschot","year":"2020","unstructured":"Verdonschot JAJ, Vanhoutte EK, Claes GRF. Helderman-van den Enden a, Hoeijmakers JGJ, Hellebrekers D, et al. A mutation update for the FLNC gene in myopathies and cardiomyopathies. Hum Mutat. 2020;41(6):1091\u2013111. https:\/\/doi.org\/10.1002\/humu.24004.","journal-title":"Hum Mutat"},{"issue":"4","key":"1423_CR75","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1001\/jamacardio.2017.5333","volume":"3","author":"LG Landry","year":"2018","unstructured":"Landry LG, Rehm HL. Association of racial\/ethnic categories with the ability of genetic tests to detect a cause of cardiomyopathy. JAMA Cardiol. 2018;3(4):341\u20135. https:\/\/doi.org\/10.1001\/jamacardio.2017.5333.","journal-title":"JAMA Cardiol"},{"issue":"3","key":"1423_CR76","doi-asserted-by":"publisher","first-page":"e013808","DOI":"10.1161\/JAHA.119.013808","volume":"9","author":"TD Pottinger","year":"2020","unstructured":"Pottinger TD, Puckelwartz MJ, Pesce LL, Robinson A, Kearns S, Pacheco JA, et al. Pathogenic and uncertain genetic variants have clinical cardiac correlates in diverse biobank participants. J Am Heart Assoc. 2020;9(3):e013808. https:\/\/doi.org\/10.1161\/JAHA.119.013808.","journal-title":"J Am Heart Assoc"},{"issue":"9","key":"1423_CR77","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1093\/eurheartj\/ehr105","volume":"32","author":"E Villard","year":"2011","unstructured":"Villard E, Perret C, Gary F, Proust C, Dilanian G, Hengstenberg C, et al. A genome-wide association study identifies two loci associated with heart failure due to dilated cardiomyopathy. Eur Heart J. 2011;32(9):1065\u201376. https:\/\/doi.org\/10.1093\/eurheartj\/ehr105.","journal-title":"Eur Heart J"},{"issue":"16","key":"1423_CR78","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1093\/eurheartj\/eht251","volume":"35","author":"B Meder","year":"2014","unstructured":"Meder B, Ruhle F, Weis T, Homuth G, Keller A, Franke J, et al. A genome-wide association study identifies 6p21 as novel risk locus for dilated cardiomyopathy. Eur Heart J. 2014;35(16):1069\u201377. https:\/\/doi.org\/10.1093\/eurheartj\/eht251.","journal-title":"Eur Heart J"},{"key":"1423_CR79","doi-asserted-by":"publisher","unstructured":"Xu H, Dorn GW 2nd, Shetty A, Parihar A, Dave T, Robinson SW, et al. A genome-wide association study of idiopathic dilated cardiomyopathy in African Americans. J Pers Med. 2018;8(1). https:\/\/doi.org\/10.3390\/jpm8010011.","DOI":"10.3390\/jpm8010011"},{"issue":"9","key":"1423_CR80","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1161\/CIRCRESAHA.120.315928","volume":"126","author":"KG Aragam","year":"2020","unstructured":"Aragam KG, Natarajan P. Polygenic scores to assess atherosclerotic cardiovascular disease risk: clinical perspectives and basic implications. Circ Res. 2020;126(9):1159\u201377. https:\/\/doi.org\/10.1161\/CIRCRESAHA.120.315928.","journal-title":"Circ Res"},{"issue":"5","key":"1423_CR81","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/s41431-019-0556-5","volume":"28","author":"H Turner","year":"2020","unstructured":"Turner H, Jackson L. Evidence for penetrance in patients without a family history of disease: a systematic review. Eur J Hum Genet. 2020;28(5):539\u201350. https:\/\/doi.org\/10.1038\/s41431-019-0556-5.","journal-title":"Eur J Hum Genet"},{"issue":"4","key":"1423_CR82","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.ajhg.2018.08.016","volume":"103","author":"MH Guo","year":"2018","unstructured":"Guo MH, Plummer L, Chan YM, Hirschhorn JN, Lippincott MF. Burden testing of rare variants identified through exome sequencing via publicly available control data. Am J Hum Genet. 2018;103(4):522\u201334. https:\/\/doi.org\/10.1016\/j.ajhg.2018.08.016.","journal-title":"Am J Hum Genet"},{"issue":"322","key":"1423_CR83","doi-asserted-by":"publisher","first-page":"322ra9","DOI":"10.1126\/scitranslmed.aad5169","volume":"8","author":"EV Minikel","year":"2016","unstructured":"Minikel EV, Vallabh SM, Lek M, Estrada K, Samocha KE, Sathirapongsasuti JF, et al. Quantifying prion disease penetrance using large population control cohorts. Sci Transl Med. 2016;8(322):322ra9. https:\/\/doi.org\/10.1126\/scitranslmed.aad5169.","journal-title":"Sci Transl Med"},{"issue":"2","key":"1423_CR84","doi-asserted-by":"publisher","first-page":"e013346","DOI":"10.1161\/JAHA.119.013346","volume":"9","author":"J Ramchand","year":"2020","unstructured":"Ramchand J, Wallis M, Macciocca I, Lynch E, Farouque O, Martyn M, et al. Prospective evaluation of the utility of whole exome sequencing in dilated cardiomyopathy. J Am Heart Assoc. 2020;9(2):e013346. https:\/\/doi.org\/10.1161\/JAHA.119.013346.","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"1423_CR85","doi-asserted-by":"publisher","first-page":"10846","DOI":"10.1038\/s41598-018-29263-3","volume":"8","author":"TSH Mak","year":"2018","unstructured":"Mak TSH, Lee YK, Tang CS, Hai JSH, Ran X, Sham PC, et al. Coverage and diagnostic yield of whole exome sequencing for the evaluation of cases with dilated and hypertrophic cardiomyopathy. Sci Rep. 2018;8(1):10846. https:\/\/doi.org\/10.1038\/s41598-018-29263-3.","journal-title":"Sci Rep"},{"issue":"3","key":"1423_CR86","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/s41436-018-0084-7","volume":"21","author":"AE Minoche","year":"2019","unstructured":"Minoche AE, Horvat C, Johnson R, Gayevskiy V, Morton SU, Drew AP, et al. Genome sequencing as a first-line genetic test in familial dilated cardiomyopathy. Genet Med. 2019;21(3):650\u201362. https:\/\/doi.org\/10.1038\/s41436-018-0084-7.","journal-title":"Genet Med"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-020-01423-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11886-020-01423-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-020-01423-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T01:46:02Z","timestamp":1633916762000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11886-020-01423-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,10]]},"references-count":86,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1423"],"URL":"https:\/\/doi.org\/10.1007\/s11886-020-01423-w","relation":{},"ISSN":["1523-3782","1534-3170"],"issn-type":[{"value":"1523-3782","type":"print"},{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,10]]},"assertion":[{"value":"14 September 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The author declares that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"170"}}